Home/Filings/4/0001209191-23-056548
4//SEC Filing

ENGLEMAN EDGAR 4

Accession 0001209191-23-056548

CIK 0001641281other

Filed

Nov 21, 7:00 PM ET

Accepted

Nov 22, 7:45 PM ET

Size

8.1 KB

Accession

0001209191-23-056548

Insider Transaction Report

Form 4
Period: 2023-11-21
ENGLEMAN EDGAR
Director10% Owner
Transactions
  • Sale

    Common Stock

    2023-11-21$0.90/sh236$213269,587 total(indirect: By Vivo Capital Surplus Fund VIII, L.P.)
  • Sale

    Common Stock

    2023-11-21$0.90/sh1,707$1,5391,952,302 total(indirect: By Vivo Capital Fund VIII, L.P.)
Footnotes (3)
  • [F1]The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.90 to $0.903, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (6) to this Form 4.
  • [F2]The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. The Reporting Person is one of the voting members of Vivo Capital VIII, LLC and may be deemed to have shared voting and dispositive power over the shares held by Vivo Capital Fund VIII, L.P. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein.
  • [F3]The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Surplus Fund VIII, L.P. The Reporting Person is one of the voting members of Vivo Capital VIII, LLC and may be deemed to have shared voting and dispositive power over the shares held by Vivo Capital Surplus Fund VIII, L.P. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein.

Issuer

Bolt Biotherapeutics, Inc.

CIK 0001641281

Entity typeother

Related Parties

1
  • filerCIK 0001227162

Filing Metadata

Form type
4
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 7:45 PM ET
Size
8.1 KB